查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446779

睡眠呼吸中止症诊断系统市场：依产品类型、最终用户、地区（北美、欧洲、亚太地区、拉丁美洲、中东非洲）：全球产业分析、规模、占有率、成长、趋势、预测 2023-2030 年

Sleep Apnea Diagnostic Systems Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030
出版日期: | 出版商: Persistence Market Research | 英文 324 Pages | 商品交期: 2-5个工作天内

价格
简介目录

持久性市场研究对全球睡眠呼吸中止症诊断系统市场进行了全面分析，提供了有关市场动态、成长动力/挑战和新兴趋势的宝贵见解。 该报告提供了预测 2023 年至 2030 年市场轨蹟的独家数据和统计数据。

全球睡眠呼吸中止症诊断系统市场预计复合年增长率为 7%，从 2023 年的 39 亿美元增加到 2030 年底的 63 亿美元。

关键见解

  • 睡眠呼吸中止症诊断系统市场规模（2023 年）：美国：39 亿美元
  • 预测市场价值（2030 年）：63 亿美元
  • 全球市场成长率（2023-2030 年复合年增长率）：7.0%
  • 过去的市场成长率（2018-2022 年复合年增长率）：4.9%

睡眠呼吸中止症诊断系统市场：调查范围

睡眠呼吸中止症诊断系统市场由一系列诊断工具和设备组成，这些工具和设备对于识别与睡眠相关的呼吸障碍（例如阻塞性睡眠呼吸中止症）非常重要。 这些系统包括多导睡眠监测仪、居家睡眠呼吸中止症测试套件和相关配件。 市场成长的主要驱动力是睡眠呼吸中止症盛行率的上升、人们对其健康影响的认识不断提高以及诊断技术的进步。 此外，由于其便利性和成本效益，家庭睡眠测试设备的日益普及也支持了市场的扩张。

市场驱动因素：

由于肥胖、久坐的生活方式和人口老化等因素，全球范围内睡眠呼吸中止症的盛行率持续上升。 这种流行，加上医疗保健专业人员和患者意识的不断提高，正在推动对诊断系统的需求。 睡眠呼吸中止症诊断设备的技术进步，例如便携式监测系统和基于云端的数据分析，正在提高诊断准确性和患者舒适度，进一步推动市场成长。

市场限制因素：

儘管存在巨大的成长机会，睡眠呼吸中止症诊断系统市场仍面临与报销政策相关的挑战，尤其是在新兴国家。 农村地区获得医疗设施和诊断服务的机会有限也阻碍了市场成长。 此外，与诊断设备相关的解释的高成本和复杂性阻碍了市场渗透，特别是在新兴市场。

市场机会：

由于技术创新和对家庭睡眠测试的日益重视，睡眠呼吸中止症诊断系统市场提供了利润丰厚的机会。 将人工智慧 (AI) 和机器学习演算法整合到诊断设备中，可以自动分析和解释睡眠数据，从而促进早期检测和个人化治疗策略。 此外，设备製造商和医疗保健提供者之间合作开发适合特定市场需求的经济实惠的诊断解决方案将为市场扩张铺平道路。

本报告涵盖的主要问题

  • 哪些地区最有可能引入睡眠呼吸中止症诊断系统？
  • 哪些因素会影响病人对居家睡眠检验与实验室多导睡眠图的偏好？
  • 科技进步如何改变睡眠呼吸中止症诊断系统市场的竞争格局？
  • 推动睡眠呼吸中止症诊断系统领域技术创新和市场拓展的主要公司有哪些？
  • 全球睡眠呼吸中止症诊断系统市场的新趋势和未来前景如何？

目录

第 1 章执行摘要

第二章市场概述

  • 市场范围与定义
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 作业
    • 主要趋势
  • 产品类型生命週期分析
  • 睡眠呼吸中止症诊断系统市场：价值链
    • 原料供应商名单
    • 製造商列表
    • 销售代理商名单
    • 申请列表
    • 获利能力分析
  • 波特五力分析
  • 地缘政治紧张局势：对市场的影响
  • 宏观经济因素
    • 世界产业展望
    • 世界 GDP 成长率展望
    • 全球母公司市场概览
  • 预测因子 - 相关性和影响
  • 监管与科技环境

第三章全球睡眠呼吸中止症候群诊断系统市场展望：过去（2018-2022年）与预测（2023-2030年）

  • 主要亮点
    • 市场容量（单位）预测
    • 市场规模及年成长率
    • 绝对的货币机会
  • 市场规模（百万美元）分析与预测
    • 过去的市场规模分析，2013-2016 年
    • 2018-2026 年目前市场规模预测
  • 全球睡眠呼吸中止症诊断系统市场前景：产品类型
    • 简介/主要发现
    • 2018-2022 年按产品类型划分的历史市场规模（百万美元）和销售量（单位）分析
    • 2023-2030 年按产品类型划分的当前市场规模（百万美元）和销售（单位）预测
      • 多导睡眠图 (PSG) 设备
      • 门诊PSG监测装置
      • 临床PSG监测装置
      • 睡眠呼吸中止症筛检装置
      • 鼻流居家护理套装
      • 週边微血管血氧饱和度 (SPO2)
      • 体动监测装置
  • 市场吸引力分析：产品类型
  • 全球睡眠呼吸中止症诊断系统市场前景：最终用户
    • 简介/主要发现
    • 2018-2022 年最终用户过去的市场规模（百万美元）和数量（单位）分析
    • 2023-2030 年最终用户的当前市场规模（百万美元）和预测销售（单位）
      • 居家照护环境
      • 医院
      • 睡眠中心和诊所
  • 市场吸引力分析：最终用户

第 4 章全球睡眠呼吸中止症候群诊断系统市场前景：地区

  • 主要亮点
  • 2018-2022 年按地区历史市场规模（百万美元）及销售量（单位）分析
  • 2023-2030 年按地区划分的当前市场规模（百万美元）和预测销售（单位）
    • 北美
    • 欧洲
    • 东亚
    • 南亚和太平洋地区
    • 拉丁美洲
    • 中东和非洲 (MEA)
  • 市场吸引力分析：地区

第五章北美睡眠呼吸中止症候群诊断系统市场展望：过去（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和销售量（单位）分析（按市场划分）
    • 依国家/地区
      • 美国
      • 加拿大
    • 依产品类型
    • 按最终用户
  • 市场吸引力分析

第6章欧洲睡眠呼吸中止症候群诊断系统市场展望：过去（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和销售量（单位）分析（按市场划分）
    • 依国家/地区
      • 德国
      • 法国
      • 英国
      • 义大利
      • 西班牙
      • 俄罗斯
      • 土耳其
      • 欧洲其他地区
    • 依产品类型
    • 按最终用户
  • 市场吸引力分析

第七章东亚睡眠呼吸中止症诊断系统市场展望：过去（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
      • 中国
      • 日本
      • 韩国
    • 依产品类型
    • 按最终用户
  • 市场吸引力分析

第8章南亚与大洋洲睡眠呼吸中止症候群诊断系统市场前景：过去（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
      • 印度
      • 东南亚
      • 纽西兰
      • 南亚和大洋洲其他地区
    • 依产品类型
    • 按最终用户
  • 市场吸引力分析

第9章拉丁美洲睡眠呼吸中止症候群诊断系统市场展望：过去（2018-2022年）与预测（2023-2030年）

  • 主要亮点
  • 价格分析
  • 2018-2022 年过去的市场规模（10,000 美元）和市场销售（单位）分析
    • 依国家/地区
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区
    • 依产品类型
    • 按最终用户
  • 市场吸引力分析

第十一章竞争态势

  • 2022 年市占率分析
  • 市场结构
    • 依市场绘製竞争强度图
    • 具有竞争力的便携式 PSG 监测设备
    • 表观产品产能
  • 公司简介（详细资料 - 概述、财务状况、策略、近期发展）
    • Koninklijke Philips NV
    • Becton, Dickinson and Company
    • Braedon Medical Corporation
    • Advanced Brain Monitoring Inc.
    • SOMNOmedics GmbH
    • ResMed Inc.
    • BMC Medical Co. Ltd.
    • Natus Medical Incorporated
    • MGC Diagnostics Corporation
    • Cleveland Medical Devices Inc.

第12章附录

  • 调查方法
  • 研究假设
  • 首字母缩写词和缩写词
简介目录
Product Code: PMRREP33725

Persistence Market Research presents a comprehensive analysis of the global Sleep Apnea Diagnostic Systems Market, offering valuable insights into market dynamics, growth drivers, challenges, and emerging trends. This report delivers exclusive data and statistics projecting the market's trajectory from 2023 to 2030.

The global sleep apnea diagnostic systems market is forecast to expand at a CAGR of 7% and thereby increase from a value of US$3.9 Bn in 2023, to US$6.3 Bn by the end of 2030..

Key Insights:

  • Sleep Apnea Diagnostic Systems Market Size (2023E): US$3.9 Billion
  • Projected Market Value (2030F): US$6.3 Billion
  • Global Market Growth Rate (CAGR 2023 to 2030): 7.0%
  • Historical Market Growth Rate (CAGR 2018 to 2022): 4.9%

Sleep Apnea Diagnostic Systems Market - Report Scope:

The Sleep Apnea Diagnostic Systems Market comprises a range of diagnostic tools and equipment crucial for identifying sleep-related breathing disorders such as obstructive sleep apnea. These systems include polysomnography devices, home sleep apnea testing kits, and related accessories. Market growth is primarily driven by the rising prevalence of sleep apnea, increasing awareness about its health implications, and advancements in diagnostic technologies. Additionally, the growing adoption of home sleep testing devices due to their convenience and cost-effectiveness fuels market expansion.

Market Growth Drivers:

The prevalence of sleep apnea continues to rise globally, propelled by factors such as obesity, sedentary lifestyles, and aging populations. This prevalence, coupled with increased awareness among healthcare professionals and patients, drives the demand for diagnostic systems. Technological advancements in sleep apnea diagnostic devices, such as portable monitoring systems and cloud-based data analytics, enhance diagnostic accuracy and patient comfort, further boosting market growth.

Market Restraints:

Despite significant growth opportunities, the Sleep Apnea Diagnostic Systems Market faces challenges related to reimbursement policies, particularly in emerging economies. Limited access to healthcare facilities and diagnostic services in rural areas also impedes market growth. Moreover, the high cost associated with diagnostic equipment and the complexity of interpretation hinder market penetration, especially in developing regions.

Market Opportunities:

The Sleep Apnea Diagnostic Systems Market offers lucrative opportunities driven by technological innovations and increasing emphasis on home-based sleep testing. Integration of artificial intelligence (AI) and machine learning algorithms in diagnostic devices enables automated analysis and interpretation of sleep data, facilitating early detection and personalized treatment strategies. Additionally, collaborations between device manufacturers and healthcare providers to develop affordable diagnostic solutions tailored to specific market needs create avenues for market expansion.

Key Questions Answered in the Report:

  • Which regions are likely to witness the highest adoption of sleep apnea diagnostic systems?
  • What factors influence patient preferences for home sleep testing versus in-laboratory polysomnography?
  • How are technological advancements reshaping the competitive landscape of the sleep apnea diagnostic systems market?
  • Who are the key players driving innovation and market expansion in the sleep apnea diagnostic systems segment?
  • What are the emerging trends and future prospects in the global sleep apnea diagnostic systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Sleep Apnea Diagnostic Systems Market, including Koninklijke Philips N.V., Becton, Dickinson and Company, Braedon Medical Corporation, and Advanced Brain Monitoring Inc., focus on product innovation and strategic collaborations to maintain market leadership. These companies invest in research and development to introduce advanced diagnostic solutions, expand their product portfolios, and gain a competitive edge. Partnerships with healthcare providers, sleep clinics, and telemedicine platforms enhance market reach and customer engagement. Moreover, investments in marketing initiatives and patient education programs contribute to market growth and brand loyalty.

Key Companies Profiled:

  • Koninklijke Philips N.V.
  • Becton, Dickinson and Company
  • Braedon Medical Corporation
  • Advanced Brain Monitoring Inc.
  • SOMNOmedics GmbH
  • ResMed Inc.
  • BMC Medical Co. Ltd.
  • Natus Medical Incorporated
  • MGC Diagnostics Corporation
  • Cleveland Medical Devices Inc.

Sleep Apnea Diagnostic Systems Market Research Segmentation:

The Sleep Apnea Diagnostic Systems Market is segmented based on the type of diagnostic systems and geographical regions.

By Product Type:

  • Polysomnography (PSG) Devices
  • Ambulatory PSG Monitoring Devices
  • Clinical PSG Monitoring Devices
  • Sleep Apnea Screening Device
  • Nasal Flow Sensors
  • Peripheral Capillary Oxygen Saturation (SPO2)
  • Actigraphy Monitoring Devices

By End-use:

  • Home Care Settings
  • Hospitals
  • Sleep Centers & Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Sleep Apnea Diagnostic Systems Market Snapshot, 2023 and 2030
  • 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Product Type Lifecycle Analysis
  • 2.4. Sleep Apnea Diagnostic Systems Market: Value Chain
    • 2.4.1. List of Raw Material Supplier
    • 2.4.2. List of Manufacturers
    • 2.4.3. List of Distributors
    • 2.4.4. List of Applications
    • 2.4.5. Profitability Analysis
  • 2.5. Porter Five Force's Analysis
  • 2.6. Geopolitical Tensions: Market Impact
  • 2.7. Macro-Economic Factors
    • 2.7.1. Global Sectorial Outlook
    • 2.7.2. Global GDP Growth Outlook
    • 2.7.3. Global Parent Market Overview
  • 2.8. Forecast Factors - Relevance and Impact
  • 2.9. Regulatory and Technology Landscape

3. Global Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 3.1. Key Highlights
    • 3.1.1. Market Volume (Units) Projections
    • 3.1.2. Market Size and Y-o-Y Growth
    • 3.1.3. Absolute $ Opportunity
  • 3.2. Market Size (US$ Mn) Analysis and Forecast
    • 3.2.1. Historical Market Size Analysis, 2013-2016
    • 3.2.2. Current Market Size Forecast, 2018-2026
  • 3.3. Global Sleep Apnea Diagnostic Systems Market Outlook: Product Type
    • 3.3.1. Introduction / Key Findings
    • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
    • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
      • 3.3.3.1. Polysomnography (PSG) Devices
      • 3.3.3.2. Ambulatory PSG Monitoring Devices
      • 3.3.3.3. Clinical PSG Monitoring Devices
      • 3.3.3.4. Sleep Apnea Screening Device
      • 3.3.3.5. Nasal Flow Home Care Settings
      • 3.3.3.6. Peripheral Capillary Oxygen Saturation (SPO2)
      • 3.3.3.7. Actigraphy Monitoring Devices
  • 3.4. Market Attractiveness Analysis: Product Type
  • 3.5. Global Sleep Apnea Diagnostic Systems Market Outlook: End User
    • 3.5.1. Introduction / Key Findings
    • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
    • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
      • 3.5.3.1. Home Care Settings
      • 3.5.3.2. Hospitals
      • 3.5.3.3. Sleep Centers & Clinics
  • 3.6. Market Attractiveness Analysis: End User

4. Global Sleep Apnea Diagnostic Systems Market Outlook: Region

  • 4.1. Key Highlights
  • 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
  • 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
    • 4.3.1. North America
    • 4.3.2. Europe
    • 4.3.3. East Asia
    • 4.3.4. South Asia & Pacific
    • 4.3.5. Latin America
    • 4.3.6. Middle East & Africa (MEA)
  • 4.4. Market Attractiveness Analysis: Region

5. North America Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 5.1. Key Highlights
  • 5.2. Pricing Analysis
  • 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 5.3.1. By Country
    • 5.3.2. By Product Type
    • 5.3.3. By End User
  • 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 5.4.1. U.S.
    • 5.4.2. Canada
  • 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 5.5.1. Polysomnography (PSG) Devices
    • 5.5.2. Ambulatory PSG Monitoring Devices
    • 5.5.3. Clinical PSG Monitoring Devices
    • 5.5.4. Sleep Apnea Screening Device
    • 5.5.5. Nasal Flow Sensors
    • 5.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 5.5.7. Actigraphy Monitoring Devices
  • 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 5.6.1. Home Care Settings
    • 5.6.2. Hospitals
    • 5.6.3. Sleep Centers & Clinics
  • 5.7. Market Attractiveness Analysis

6. Europe Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 6.1. Key Highlights
  • 6.2. Pricing Analysis
  • 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 6.3.1. By Country
    • 6.3.2. By Product Type
    • 6.3.3. By End User
  • 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 6.4.1. Germany
    • 6.4.2. France
    • 6.4.3. U.K.
    • 6.4.4. Italy
    • 6.4.5. Spain
    • 6.4.6. Russia
    • 6.4.7. Turkey
    • 6.4.8. Rest of Europe
  • 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 6.5.1. Polysomnography (PSG) Devices
    • 6.5.2. Ambulatory PSG Monitoring Devices
    • 6.5.3. Clinical PSG Monitoring Devices
    • 6.5.4. Sleep Apnea Screening Device
    • 6.5.5. Nasal Flow Sensors
    • 6.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 6.5.7. Actigraphy Monitoring Devices
  • 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 6.6.1. Home Care Settings
    • 6.6.2. Hospitals
    • 6.6.3. Sleep Centers & Clinics
  • 6.7. Market Attractiveness Analysis

7. East Asia Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 7.3.1. By Country
    • 7.3.2. By Product Type
    • 7.3.3. By End User
  • 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 7.4.1. China
    • 7.4.2. Japan
    • 7.4.3. South Korea
  • 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 7.5.1. Polysomnography (PSG) Devices
    • 7.5.2. Ambulatory PSG Monitoring Devices
    • 7.5.3. Clinical PSG Monitoring Devices
    • 7.5.4. Sleep Apnea Screening Device
    • 7.5.5. Nasal Flow Sensors
    • 7.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 7.5.7. Actigraphy Monitoring Devices
  • 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 7.6.1. Home Care Settings
    • 7.6.2. Hospitals
    • 7.6.3. Sleep Centers & Clinics
  • 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By End User
  • 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 8.4.1. India
    • 8.4.2. Southeast Asia
    • 8.4.3. ANZ
    • 8.4.4. Rest of South Asia & Oceania
  • 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 8.5.1. Polysomnography (PSG) Devices
    • 8.5.2. Ambulatory PSG Monitoring Devices
    • 8.5.3. Clinical PSG Monitoring Devices
    • 8.5.4. Sleep Apnea Screening Device
    • 8.5.5. Nasal Flow Sensors
    • 8.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 8.5.7. Actigraphy Monitoring Devices
  • 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 8.6.1. Home Care Settings
    • 8.6.2. Hospitals
    • 8.6.3. Sleep Centers & Clinics
  • 8.7. Market Attractiveness Analysis

9. Latin America Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By End User
  • 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 9.5.1. Polysomnography (PSG) Devices
    • 9.5.2. Ambulatory PSG Monitoring Devices
    • 9.5.3. Clinical PSG Monitoring Devices
    • 9.5.4. Sleep Apnea Screening Device
    • 9.5.5. Nasal Flow Sensors
    • 9.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 9.5.7. Actigraphy Monitoring Devices
  • 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 9.6.1. Home Care Settings
    • 9.6.2. Hospitals
    • 9.6.3. Sleep Centers & Clinics
  • 9.7. Market Attractiveness Analysis

10. Middle East & Africa Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
    • 10.3.1. By Country
    • 10.3.2. By Product Type
    • 10.3.3. By End User
  • 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
    • 10.4.1. GCC
    • 10.4.2. Egypt
    • 10.4.3. South Africa
    • 10.4.4. Northern Africa
    • 10.4.5. Rest of Middle East & Africa
  • 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 10.5.1. Polysomnography (PSG) Devices
    • 10.5.2. Ambulatory PSG Monitoring Devices
    • 10.5.3. Clinical PSG Monitoring Devices
    • 10.5.4. Sleep Apnea Screening Device
    • 10.5.5. Nasal Flow Sensors
    • 10.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 10.5.7. Actigraphy Monitoring Devices
  • 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 10.6.1. Home Care Settings
    • 10.6.2. Hospitals
    • 10.6.3. Sleep Centers & Clinics
  • 10.7. Market Attractiveness Analysis

11. Competition Landscape

  • 11.1. Market Share Analysis, 2022
  • 11.2. Market Structure
    • 11.2.1. Competition Intensity Mapping By Market
    • 11.2.2. Competition Ambulatory PSG Monitoring Devices
    • 11.2.3. Apparent Product Capacity
  • 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 11.3.1. Koninklijke Philips N.V.
      • 11.3.1.1. Overview
      • 11.3.1.2. Segments and Product
      • 11.3.1.3. Key Financials
      • 11.3.1.4. Market Developments
      • 11.3.1.5. Market Strategy
    • 11.3.2. Becton, Dickinson and Company
      • 11.3.2.1. Overview
      • 11.3.2.2. Segments and Product
      • 11.3.2.3. Key Financials
      • 11.3.2.4. Market Developments
      • 11.3.2.5. Market Strategy
    • 11.3.3. Braedon Medical Corporation
      • 11.3.3.1. Overview
      • 11.3.3.2. Segments and Product
      • 11.3.3.3. Key Financials
      • 11.3.3.4. Market Developments
      • 11.3.3.5. Market Strategy
    • 11.3.4. Advanced Brain Monitoring Inc.
      • 11.3.4.1. Overview
      • 11.3.4.2. Segments and Product
      • 11.3.4.3. Key Financials
      • 11.3.4.4. Market Developments
      • 11.3.4.5. Market Strategy
    • 11.3.5. SOMNOmedics GmbH
      • 11.3.5.1. Overview
      • 11.3.5.2. Segments and Product
      • 11.3.5.3. Key Financials
      • 11.3.5.4. Market Developments
      • 11.3.5.5. Market Strategy
    • 11.3.6. ResMed Inc.
      • 11.3.6.1. Overview
      • 11.3.6.2. Segments and Product
      • 11.3.6.3. Key Financials
      • 11.3.6.4. Market Developments
      • 11.3.6.5. Market Strategy
    • 11.3.7. BMC Medical Co. Ltd.
      • 11.3.7.1. Overview
      • 11.3.7.2. Segments and Product
      • 11.3.7.3. Key Financials
      • 11.3.7.4. Market Developments
      • 11.3.7.5. Market Strategy
    • 11.3.8. Natus Medical Incorporated
      • 11.3.8.1. Overview
      • 11.3.8.2. Segments and Product
      • 11.3.8.3. Key Financials
      • 11.3.8.4. Market Developments
      • 11.3.8.5. Market Strategy
    • 11.3.9. MGC Diagnostics Corporation
      • 11.3.9.1. Overview
      • 11.3.9.2. Segments and Product
      • 11.3.9.3. Key Financials
      • 11.3.9.4. Market Developments
      • 11.3.9.5. Market Strategy
    • 11.3.10. Cleveland Medical Devices Inc.
      • 11.3.10.1. Overview
      • 11.3.10.2. Segments and Product
      • 11.3.10.3. Key Financials
      • 11.3.10.4. Market Developments
      • 11.3.10.5. Market Strategy

12. Appendix

  • 12.1. Research Methodology
  • 12.2. Research Assumptions
  • 12.3. Acronyms and Abbreviations